Latest news
OMER Stock Gains 4% — CMS Green-Lights $287K Add-On Payments For Transplant Drug - StocktwitsStocktwits · Fri, 07 Aug 2026 23:50:51 GMTOmeros (OMER) Gains CMS NTAP Approval for Yartemlea, But Valuati - GuruFocusGuruFocus · Mon, 03 Aug 2026 15:11:04 GMTCeriBell (CBLL) Gains CMS Approval for NTAP, Highlighting Growth Potential Despite Profitability Challenges - GuruFocusGuruFocus · Mon, 03 Aug 2026 13:09:25 GMT